Omnicell, Inc. (OMCL)
NASDAQ: OMCL · IEX Real-Time Price · USD
29.29
0.00 (0.00%)
At close: May 3, 2024, 4:00 PM
30.71
+1.42 (4.85%)
After-hours: May 3, 2024, 5:20 PM EDT
Omnicell Employees
Omnicell had 3,650 employees on December 31, 2023. The number of employees decreased by 580 or -13.71% compared to the previous year.
Employees
3,650
Change (1Y)
-580
Growth (1Y)
-13.71%
Revenue / Employee
$314,277
Profits / Employee
-$5,581
Market Cap
1.38B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 3,650 | -580 | -13.71% |
Dec 31, 2022 | 4,230 | 430 | 11.32% |
Dec 31, 2021 | 3,800 | 940 | 32.87% |
Dec 31, 2020 | 2,860 | 160 | 5.93% |
Dec 31, 2019 | 2,700 | 220 | 8.87% |
Dec 31, 2018 | 2,480 | 130 | 5.53% |
Dec 31, 2017 | 2,350 | -94 | -3.85% |
Dec 31, 2016 | 2,444 | 993 | 68.44% |
Dec 31, 2015 | 1,451 | 215 | 17.39% |
Dec 31, 2014 | 1,236 | 102 | 8.99% |
Dec 31, 2013 | 1,134 | 45 | 4.13% |
Dec 31, 2012 | 1,089 | 316 | 40.88% |
Dec 31, 2011 | 773 | 20 | 2.66% |
Dec 31, 2010 | 753 | 0 | - |
Dec 31, 2009 | 753 | -91 | -10.78% |
Dec 31, 2008 | 844 | 38 | 4.71% |
Dec 31, 2007 | 806 | 180 | 28.75% |
Dec 31, 2006 | 626 | 112 | 21.79% |
Dec 31, 2005 | 514 | 26 | 5.33% |
Dec 31, 2004 | 488 | 56 | 12.96% |
Dec 31, 2003 | 432 | 82 | 23.43% |
Dec 31, 2002 | 350 | -25 | -6.67% |
Dec 31, 2001 | 375 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Brookdale Senior Living | 36,000 |
Pacira BioSciences | 712 |
Ironwood Pharmaceuticals | 267 |
4D Molecular Therapeutics | 147 |
Ligand Pharmaceuticals | 58 |
Akero Therapeutics | 56 |
OMCL News
- 20 hours ago - Omnicell to Present at the BofA Securities 2024 Health Care Conference - Business Wire
- 2 days ago - Omnicell Announces First Quarter 2024 Results - Business Wire
- 17 days ago - Omnicell Announces XT Amplify - Business Wire
- 25 days ago - Omnicell to Release First Quarter 2024 Financial Results on May 2, 2024 - Business Wire
- 7 weeks ago - Omnicell to Present at the virtual KeyBanc Annual Life Sciences & MedTech Investor Forum - Business Wire
- 3 months ago - Omnicell Announces Fiscal Year and Fourth Quarter 2023 Results - Business Wire
- 3 months ago - Omnicell to Release Fourth Quarter and Full Year 2023 Financial Results on February 8, 2024 - Business Wire
- 4 months ago - Omnicell Elects Eileen Voynick to Board of Directors - Business Wire